πŸ‡ΊπŸ‡Έ FDA
Patent

US 12410132

Antiplatelet drugs and uses thereof

granted A61KA61K31/445A61K31/4525

Quick answer

US patent 12410132 (Antiplatelet drugs and uses thereof) held by SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD.
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/445, A61K31/4525, A61P, A61P7/02